Frenel, J.-S. http://orcid.org/0000-0002-5273-0561
Lusque, A.
Delaloge, S. http://orcid.org/0000-0003-2106-9165
Ferrero, J.-M.
Bachelot, T. http://orcid.org/0000-0002-0866-9484
Desmoulins, I.
Levy, C.
Eymard, J.-C.
Gonçalves, A.
Patsouris, A. http://orcid.org/0000-0001-9101-5424
Reynier, M. A. Mouret
Thery, M. J.-C.
Petit, T.
Cabel, L. http://orcid.org/0000-0001-5515-9180
Uwer, L.
Debled, M.
Chevrot, M.
Mailliez, A.
Jacot, W. http://orcid.org/0000-0001-7834-061X
de La Motte Rouge, T.
Article History
Received: 13 October 2022
Revised: 6 March 2023
Accepted: 20 March 2023
First Online: 3 April 2023
Competing interests
: JSF reports personal fees from Roche Genentech, personal fees and non-financial support from SeattleGenetics, personal fees and non-financial support from Novartis, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Lilly, personal fees and non-financial support from Novartis, personal fees and non-financial support from GSK, personal fees and non-financial support from Clovis oncoloy, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from Daiichi Sankyo, personal fees and non-financial support from Gilead, personal fees and non-financial support from MSD, personal fees and non-financial support from Pierre Fabre, personal fees and non-financial support from Amgen, outside the submitted work. AL has declared no conflict of interest. SD reports grants and non-financial support from Pfizer, grants from Novartis, grants and non-financial support from Astra Zeneca, grants and non-financial support from Roche Genentech, grants from Lilly, grants from Puma, grants from Myriad, grants from Orion, grants from Amgen, grants from Sanofi, grants from Genomic Health, grants from GE, grants from Servier, grants from MSD, grants from BMS, grants from Pierre Fabre, grants from Seagen, grants from Exact Sciences, grants from Rappta, grants from Besins, grants from European Commission, grants from French government grants, grants from Fondation ARC, outside the submitted work. JMF reports personal fees from Pfizer, Novartis, Pierre Fabre, Lilly. TB reports personal fees and non-financial support from Roche, grants, personal fees and non-financial support from Astra Zeneca, grants, personal fees and non-financial support from Pfizer, grants and personal fees from SeaGen, grants, personal fees and non-financial support from Novartis, outside the submitted work; ID has declared no conflict of interest. CL has received reports personal fees from Daiichi, Astra Zeneca, Lilly, MSD. JCE has declared no conflict of interest. AG has declared no conflict of interest. AP reports from Lilly, other from Daiichi-Sankyo, other from Pfizer, other from Pierre Fabre, outside the submitted work; MAM has declared no conflict of interest. JCT has received reports personal fees from PFIZER, personal fees from MSD, personal fees from ASTRAZENECA, non-financial support from NOVARTIS, outside the submitted work. TP eports personal fees and non-financial support from Pfizer, personal fees from Lilly, personal fees and non-financial support from Novartis, personal fees and non-financial support from Astra-Zeneca, personal fees from Seagen, personal fees and non-financial support from Daiichi Sankyo, personal fees from Pierre Fabre, outside the submitted work. LC has declared no conflict of interest. LU has declared no conflict of interest. MD has declared no conflict of interest. MC has declared no conflict of interest. AM has declared no conflict of interest. WJ reports personal fees and non-financial support from Novartis, grants, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from Roche Genentech, personal fees and non-financial support from Lilly, non-financial support from Sanofi, personal fees from Daiichi Sankyo, personal fees from MSD, personal fees from Rain Pharmaceuticals, non-financial support from Pierre Fabre, personal fees from Seagen, personal fees from BMS, personal fees and non-financial support from Eisai, personal fees and non-financial support from Pfizer, non-financial support from Glaxo Smithkline, non-financial support from Chugai Pharma, outside the submitted work. TDLM reports grants from Novartis, grants, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from Roche Genentech, grants and personal fees from MSD, grants from Seagen, personal fees from Eisai, grants, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Glaxo Smithkline, personal fees and non-financial support from CLOVIS ONCOLOGY, outside the submitted work.
: ESME MBC database was authorised by the French data protection authority (Registration ID 1704113 and authorisation N°DE-2013.-117).